Hear What Previous Attendees Have to Say
Hear from attendees across all previous editions of the iPSC Drug Development Summit.
The iPSC field has entered a pivotal phase, as developers move beyond early research and focus on overcoming the manufacturing, characterization, scalability, and regulatory challenges standing between promising therapies and clinical impact. With increasing investment, accelerating clinical progress, and growing expectations for commercially viable iPSC-derived products, this is the most important year yet to attend the 6th iPSC Drug Development Summit and shape the next 20 years of iPSC development.
"I found speakers were interactive and open to discuss problems and potential solutions in developing iPSC drug product. Concern about the safety and regulatory aspect of iPSC drug manufacturing discussion was most stood out to me."
AstraZeneca
"I liked the small, intimate nature of the conference. The collaboration and discussion sessions at the tables in the smaller setting really worked well."
Roslin Cell Therapies
"It’s an amazing conference that covers both R&D and manufacturing perspectives of iPSC. The well-organized program offers not only the opportunity to learn the cutting-edge technologies, but also the excellent networking opportunities with so many leaders and experts in this area."
University of California Los Angeles
"Each year the speaker lineup gets better and more relevant for our research programs."
FUJIFILM Cellular Dynamics Inc
"Great opportunity to learn and network with individuals in iPSC space. I appreciated the different topics in CMC and pre-clinical."
Sana Biotechnology
"I enjoyed all the speakers (great agenda) and the ease to connect with people. The speed networking session was good!"
BlueRock Therapeutics
"Really appreciated the narrow focus of the meeting, and the presentation quality was pretty good."
Lineage Cell Therapeutics Inc.
"The conference had some great speakers and attended by relevant attendees that made the participation in the exhibition worthwhile."
bit.bio
"The talks were high quality and well organized. It was valuable to hear diverse perspectives on iPSC applications, and the networking opportunities stood out."
Harvard Medical School
Explore the Agenda
See where the bottlenecks really are and how teams are solving them.
This agenda goes beyond theory to highlight the decisions shaping real iPSC programs, from line selection and genome integrity to late stage scale up, comparability, and regulatory confidence.
Partner With Us
Shape the discussion at the point where priorities are being set.
Partnering with the summit gives you a unique opportunity to position your organization at the heart of the iPSC community, build meaningful connections, and become the go-to partner for the iPSC community.
Join the iPSC Community
Connect with a field that has moved past experimentation.
Meet a focused community of leaders working through the realities of clinical translation, manufacturing scale, and regulatory alignment. Biopharma and academics can attend for free!